Decrease of serum levels of soluble CD23 during immunotherapy in patients with perennial allergic rhinitis.

@article{Tanaka1999DecreaseOS,
  title={Decrease of serum levels of soluble CD23 during immunotherapy in patients with perennial allergic rhinitis.},
  author={Akemi Tanaka and Yohei Ohashi and Yuichiro Nakai},
  journal={The Annals of otology, rhinology, and laryngology},
  year={1999},
  volume={108 2},
  pages={193-200}
}
There is increasing in vitro evidence that soluble CD23 (sCD23) is capable of potentiating the synthesis of human IgE and is likely involved in the expression of allergic diseases. Our study has aimed at investigating whether serum sCD23 is elevated in patients with perennial allergic rhinitis as compared to nonatopic controls, whether sCD23 in perennial… CONTINUE READING